Clariant has unveiled Beracare CBA, a skincare active consisting of a complex blend of Amazon oils to produce a natural alternative to cannabidiol.
Beracare CBA combines copaiba oil with passion fruit oil, both of which are harvested sustainably, to soothe sensitive skin.
The active provides a CBD-like effect by targeting the skin’s endocannabinoid system, activating the CB2 receptors.
This helps increase the production of β-endorphin, creating a superior soothing effect compared to CBD.
New data enrich previous studies and show that Beracare CBA effectively reduces skin sensitivity by 61% after seven days and 71% after 28 days, decreasing redness and irritation.
“With their recognized potential for promoting overall skin wellness, products using cannabidiol are attracting increased attention. Yet, CBD faces regulatory concerns in many countries,” said Julie Droux, Global Technical Marketing Manager for Actives and Natural Origins.
“With Beracare CBA, Clariant is offering a powerful, natural alternative without the regulatory challenges,” she added.
